
2 minute read
Coronavirus Action Fund: Helping Win the Global Race against COVID-19
As the COVID-19 pandemic enters a third year, and variants such as Omicron continue to emerge, identification of effective treatments remains critical.
Thanks to the generosity of you, our donors, the RBWH Foundation Coronavirus Action Fund continues to help fund the global search for treatments and patient care protocols through the Australasian COVID-19 (ASCOT) Trial.
Advertisement
More than 1500 patients have been recruited from 42 hospitals across Australia, New Zealand, India and Nepal.
Professor David Paterson, RBWH Consultant Infectious Diseases Physician
It is expected that ASCOT reporting will make a substantial contribution to existing global knowledge and datasets.
One of the key findings has been ruling out convalescent plasma, which is manufactured from the blood of recovered patients, as an effective therapy.

The next focus will be prevention of blood clots.
Your support of the Coronavirus Action Fund is helping fund these ongoing COVID-19 research projects:
• The impact of life-support equipment on COVID-19 drugs
• Long-term COVID-19 side-effects
• The impact of telehealth/virtual care on Heart Failure and Pulmonary Rehabilitation patient care
• Face time and virtual visiting of patients in ICU
• Changes in gestational diabetes testing
• Impacts on maternal depression and related disorders
• A new fast, low-cost COVID-19 test
• RBWH Emergency Operations Centre’s response to COVID-19: barriers and enablers
• RBWH Specialist Outpatient Services virtual care evaluation.